Ledger.Open graph →
SEC Form D · filed February 9, 2021

Opna Immuno-Oncology SA

Offering
Sold
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ST SULPICE, V8
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Douglas Hanahan · St Sulpice, V8DirectorBrian W. Pusch · New York, NYDirectorJoseph W. Schlessinger · Woodbridge, CTDirectorRichard A. Cohen · LONGUEUIL, Quebec, CanadaDirectorCarole N. Plante · LONGUEUIL, Quebec, CanadaDirectorLorenzo Di Mattia · New York, NYDirectorGideon W. Bollag · Orinda, CADirectorEric M. Tooker · Scottsdale, AZDirectorDavid Lichtblau · San Francisco, CADirectorDavid S. Washburn · Allendale, NJDirectorGideon W. Bollag · Orinda, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗